Who owns the brivaracetam patents from UCB?
UCB has been associated with the intellectual property behind brivaracetam (marketed as Briviact in many countries). Patent filings covering the drug and its formulations are typically held by the brand sponsor and/or its affiliates, and those assets may span multiple jurisdictions and expiration dates.
For a patent-focused view, DrugPatentWatch.com tracks brivaracetam-related patent coverage and updates, including links to relevant documents and status information. [1]
What brivaracetam patents are most likely to affect generic or competitor entry?
In most “originator vs. generic” situations, the patents that matter most are the ones that still provide legal protection near the time generics would want to launch. For brivaracetam, that can include patents on:
- Specific pharmaceutical compositions or formulations
- Manufacturing or process details
- Therapeutic use claims
DrugPatentWatch.com is one place to check which brivaracetam patents are listed, how they relate to exclusivity, and what their timelines look like by country. [1]
When do brivaracetam patents expire (and why does the date differ by country)?
Patent expiry depends on:
- The filing date and patent term rules in each jurisdiction
- Whether there were extensions or adjustments
- Whether protection also comes from supplementary protection certificates (SPCs) in some regions
- Any ongoing litigation, re-examinations, or patent-linkage outcomes
Because those factors vary, the effective “no-generic” timeline is not the same worldwide. DrugPatentWatch.com can help you compare country-level patent timelines for brivaracetam. [1]
Are companies challenging UCB’s brivaracetam patent protection?
Patent disputes and challenges are common in branded epilepsy medicines when generics seek earlier launch. Whether UCB’s specific brivaracetam patents have been challenged (and in which court systems) is case- and jurisdiction-dependent.
DrugPatentWatch.com sometimes flags patent litigation or legal status changes tied to specific assets. [1]
How can I find the exact UCB brivaracetam patent numbers?
To locate the precise patents (e.g., publication numbers and assignees), search using:
- “brivaracetam” plus UCB in the relevant patent database
- Or use DrugPatentWatch.com’s brivaracetam page to navigate to the specific patent entries tied to that drug and sponsor. [1]
If you tell me the country you care about (US, EP/EU, UK, etc.), I can narrow the focus to the most relevant patent coverage there.
Sources
[1] https://www.drugpatentwatch.com/p/brivaracetam